Replies to Post #283 onAbbvie Inc (ABBV)

Replies to post #283 on Abbvie Inc (ABBV)

Replies to #283 on Abbvie Inc (ABBV)

10/27/16 6:47 PM

#287 RE: DewDiligence #283

AMGN not launching Amjevita—(Humira FoB)—until 2018 or later:

Relevant to $MNTA. https://t.co/XHbmBsL9ul
— Roy Friedman (@DewDiligence) October 27, 2016

01/27/17 10:45 AM

#301 RE: DewDiligence #283

CHMP approves AMGN’s Humira FoB: #msg-128199069.